What are the latest drug market trends and what are the factors driving them? What drugs are causing the most concern today? What are the most recent developments in drug prevention, treatment and policy? These, and other, questions will be explored by the EU drugs agency (EMCDDA) on 7 June in its annual overview of the European drug situation.
The European Drug Report 2018: Trends and Developments, provides a comprehensive analysis of patterns emerging across the 28 EU Member States, Turkey and Norway. In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report will be the 2018 Statistical Bulletin, containing the European dataset underpinning the analysis.
The report will be complemented by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these online reports cover: drug use and public health problems; drug policy and responses and drug supply.
Date: 7 June 2018
Time: 11:30 Central European Time/CET (10:30 Western European Time/WET/Lisbon) (to be confirmed).
Venue: European Commission, Berlaymont, Brussels (to be confirmed).
Press conference: In the presence of Dimitris Avramopoulos, European Commissioner responsible for Migration, Home Affairs and Citizenship and Alexis Goosdeel, EMCDDA Director.
Contact: EMCDDA press office.
European Commission spokespersonsʼ service — Tove Ernst (32) 2 298 67 64; Katarzyna Kolanko (32) 2 296 34 44.
Interviews: EMCDDA representatives will be available on the day of the launch to answer journalistsʼ questions. Across Europe, staff at the Reitox national focal points will answer country-specific queries (interview details available via the link below).
Find out more: www.emcdda.europa.eu/edr2018